Promet Therapeutic LLC
Processa Pharmaceuticals Inc. is a development-stage pharmaceutical company based in Hanover, MD, dedicated to improving the quality of life for patients with unmet medical needs. With a focus on oncology and other high unmet medical need diseases, Processa uses a unique approach to develop effective pharmacological solutions that address critical patient needs. Their drug candidates, including Metastatic Colorectal and Breast Cancer PCS6422, Ulcerative Necrobiosis Lipoidica NL PCS499, and Gastroparesis PCS12852, aim to provide safer and more effective treatments for patients with limited treatment options. Processa Pharmaceuticals Inc. stands out from other pharmaceutical companies due to its leadership team's extensive experience in R&D and regulatory expertise, which allows for efficient drug development and positioning for approval success. Their patient-centric approach ensures that the needs of patients and caregivers are at the forefront of their programs, allocating resources to accelerate the development of life-improving solutions. With a commitment to de-risked development and a higher probability of success, Processa Pharmaceuticals Inc. strives to make a positive impact on the lives of patients and their families.Generated from the website